GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7MZG | 7MZG | SARS-CoV-2 receptor binding domain bound to Fab PDI 42 | |
7MZH | 7MZH | SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 | |
7MZI | 7MZI | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 | |
7MZJ | 7MZJ | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93 | |
7MZK | 7MZK | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
7MZL | 7MZL | SARS-CoV-2 receptor binding domain bound to Fab PDI 210 | |
7MZM | 7MZM | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
7MZN | 7MZN | SARS-CoV-2 receptor binding domain bound to Fab PDI 231 | |
7N04 | 7N04 | Crystal structure of the apo F240 antibody fragment | |
7N0A | 7N0A | Structure of Human Leukaemia Inhibitory Factor with Fab MSC1 | |
7N0G | 7N0G | CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) | |
7N0H | 7N0H | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
7N0U | 7N0U | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
7N19 | 7N19 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
7N28 | 7N28 | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J033 in complex with HIV-1 Env | |
7N2N | 7N2N | TCR-antigen complex AS4.2-PRPF3-HLA*B27 | |
7N2O | 7N2O | AS4.2-YEIH-HLA*B27 | |
7N2P | 7N2P | AS4.3-RNASEH2b-HLA*B27 | |
7N2Q | 7N2Q | AS4.3-YEIH-HLA*B27 | |
7N2R | 7N2R | AS4.3-PRPF3-HLA*B27 | |
7N2S | 7N2S | AS3.1-PRPF3-HLA*B27 | |
7N3I | 7N3I | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7N3T | 7N3T | TrkA ECD complex with designed miniprotein ligand | |
7N4I | 7N4I | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
7N4J | 7N4J | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
7N4M | 7N4M | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
7N5H | 7N5H | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7N62 | 7N62 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N64 | 7N64 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7N65 | 7N65 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7N8Q | 7N8Q | Rhesusized RV305 DH677.3 Fab bound to Clade A/E 93TH057 HIV-1 gp120 core. | |
7NAM | 7NAM | LRP6_E1 in complex with Lr-EET-3.5 | |
7ND3 | 7ND3 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND4 | 7ND4 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND5 | 7ND5 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND6 | 7ND6 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND7 | 7ND7 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND8 | 7ND8 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND9 | 7ND9 | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDA | 7NDA | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDB | 7NDB | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDC | 7NDC | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDD | 7NDD | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NE0 | 7NE0 | Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin | |
7NE0 | 7NE0 | Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin | |
7NEF | 7NEF | Fucosylated linear peptide Fln65 bound to the fucose binding lectin LecB PA-IIL from Pseudomonas aeruginosa at 1.5 Angstrom resolution | |
7NEG | 7NEG | Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab | |
7NEH | 7NEH | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024